Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Hite ChristopherEVP & Chairman, Partnering |  RPRXRoyalty Pharma plcGrant or award | A | — 11.0K sh | Aug 7, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner |  PUBMPubMatic, Inc.Derivative conversion · 10b5-1 plan | C | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 4 | Werner Ryan D.SVP, CAO |  RIOTRiot Platforms, Inc.Open-market sale · 10b5-1 plan | SELL | $59K 2,501 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 4 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOption exercise · 10b5-1 plan | M | $9,840 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 4 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOption exercise · 10b5-1 plan | M | — 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 4 | Werner Ryan D.SVP, CAO | RIOTRiot Platforms, Inc. Open-market sale · 10b5-1 plan | SELL | $224K 9,802 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 3 | Ditillo DavidChief Information Officer |  CRBGCorebridge Financial, Inc.Option exercise · 10b5-1 plan | M | — 3,914 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 3 | Walsh Mark T.Director, CEO & Director |  SVVSavers Value Village, Inc.Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 3 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 2 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpGrant or award | A | — 15.00M sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Grant or award | A | — 11.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 2 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOption exercise · 10b5-1 plan | M | $104K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 2 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Grant or award | A | — 8,252 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Grant or award | A | — 15.00M sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Geisser Melinda L.Chief People Services Officer | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Option exercise · 10b5-1 plan | M | — 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $44K 15.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $23K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 14.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | PUBMPubMatic, Inc. Option exercise · 10b5-1 plan | M | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $11K 7,941 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $7,050 5,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Option exercise · 10b5-1 plan | M | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Option exercise · 10b5-1 plan | M | $230K 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $11K 7,941 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $44K 15.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | PUBMPubMatic, Inc. Derivative conversion · 10b5-1 plan | C | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $7,050 5,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $33K 23.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Ditillo DavidChief Information Officer | CRBGCorebridge Financial, Inc. Option exercise · 10b5-1 plan | M | $79K 3,914 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Mayes Patrick AEVP & Chief Scientific Officer |  INCYINCYTE CORPOption exercise · 10b5-1 plan | M | — 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $9,840 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $23K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |